Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Feb. 5, 2019. Lydia Pace, Stacie Dusetzina, Mara Murray Horwitz & Nancy Keating.

Executive Summary

The four authors say their study, published in JAMA Internal Medicine on Feb. 4, shows a 22% increase in the use of contraceptive intrauterine devices (IUDs) by women in the 30 days following the Nov. 8, 2016, US election. Read why they think that happened here.

"The [Affordable Care Act's] contraceptive coverage mandate is an important strategy to reduce unintended pregnancies. The Trump administration has weakened this mandate. Our findings could reflect a response to fears of losing contraceptive coverage because of President Trump's opposition to the ACA." –Lydia Pace, Stacie Dusetzina, Mara Murray Horwitz & Nancy Keating, authors, "Utilization of Long-Acting Reversible Contraceptives in the United States After vs Before the 2016 US Presidential Election," JAMA Internal Medicine

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT124593

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel